文献速递静脉血栓栓塞

巴西三甲医院COVID-19住院患者深静脉血栓:发生率、分布、预测因素与临床结局

Deep Vein Thrombosis in Hospitalized Patients with COVID-19: Incidence, Distribution, Predictors, and Clinical Outcomes in a Brazilian Tertiary Center.
PubMed 文献 · Ann Vasc Surg · 2026-07-28

该回顾性队列纳入2020至2024年5831例COVID-19住院患者,分析深静脉血栓(DVT)的发生率、解剖分布、独立预测因素及临床结局。DVT虽不常见,但与疾病严重程度密切相关,既往DVT史是最强预测因素,发生DVT者住院死亡率和肺栓塞发生率显著更高。

要点

  • COVID-19住院患者中DVT虽不常见,但一旦发生与高发病率和高死亡率相关。
  • 既往DVT史是最强独立预测因素(aOR=18.3),肥胖、吸烟和需氧治疗亦为独立预测因素。
  • 发生DVT者住院死亡率37.7%、肺栓塞15.9%,均显著高于无DVT者。

核心结论

  • COVID-19住院患者中DVT不常见,但与显著的发病率和死亡率相关。
  • 既往静脉血栓史是最强预测因素,可识别高危亚组。
  • 尽管常规药物预防,仍有临床显著DVT发生,支持需风险适配的诊断策略,包括针对性静脉多普勒超声。

研究设计与样本

  • 巴西三级医疗中心回顾性队列研究,纳入5831例有完整DVT数据的COVID-19住院患者(2020-2024年)。
  • 分析人口学特征、合并症、影像学表现和临床结局,采用多变量logistic回归识别独立预测因素并以aOR报告。

主要发现

  • DVT患者ICU入住率、机械通气率、住院时间和院内死亡率均更高(中位住院24 vs 8天,P<0.001;院内死亡率37.7% vs 11.1%,P<0.001)。
  • DVT患者肺栓塞更常见(15.9% vs 1.2%,P<0.001)。
  • 独立预测因素包括既往DVT(aOR=18.3;95%CI 5.22-63.9)、肥胖(aOR=3.21;95%CI 1.92-5.38)、吸烟(aOR=2.59;95%CI 1.26-5.34)和需氧治疗(aOR=4.86;95%CI 2.35-10.1)。
  • 大多数事件为急性,主要累及左下肢。

关键数值与推荐

  • 既往DVT史aOR=18.3(95%CI 5.22-63.9),为最强独立预测因素。
  • 肥胖aOR=3.21(95%CI 1.92-5.38),吸烟aOR=2.59(95%CI 1.26-5.34),需氧治疗aOR=4.86(95%CI 2.35-10.1)。
  • DVT患者院内死亡率37.7% vs 11.1%(P<0.001),肺栓塞15.9% vs 1.2%(P<0.001)。

临床怎么用

  • 对COVID-19住院患者应评估既往DVT史、肥胖、吸烟和需氧治疗等DVT预测因素。
  • 对高危患者可考虑针对性静脉多普勒超声筛查,尽管常规药物预防仍可能发生DVT。

局限性

  • 回顾性单中心研究设计可能引入选择偏倚和信息偏倚。
  • 仅纳入有完整DVT数据的住院患者,可能低估真实发生率。
  • 未报告常规药物预防的具体方案和依从性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aimed to assess the incidence, anatomical distribution, and independent clinical predictors of deep vein thrombosis (DVT) among patients hospitalized with COVID-19 in a Brazilian tertiary-care center. METHODS: This retrospective cohort study included 5,831 hospital admissions (2020-2024) with complete DVT data. Demographic characteristics, comorbidities, imaging findings, and clinical outcomes were analyzed. Independent predictors of DVT were identified using multivariable logistic regression and reported as adjusted odds ratios (aORs). RESULTS: DVT was infrequent but strongly associated with COVID-19 severity. Patients with DVT had higher rates of intensive care unit admission, mechanical ventilation, prolonged hospitalization (median 24 vs. 8 days; P < 0.001), and in-hospital mortality (37.7% vs. 11.1%; P < 0.001). Pulmonary embolism was more common among patients with DVT (15.9% vs. 1.2%; P < 0.001). Independent predictors of DVT included prior DVT (aOR = 18.3; 95% confidence interval [CI], 5.22-63.9), obesity (aOR = 3.21; 95% CI, 1.92-5.38), smoking (aOR 2.59; 95% CI, 1.26-5.34), and oxygen requirement (aOR = 4.86; 95% CI, 2.35-10.1). Most events were acute and predominantly involved the left lower extremity. CONCLUSION: Although uncommon, DVT in hospitalized COVID-19 patients was associated with substantial morbidity and mortality. A prior history of venous thrombosis was the strongest predictor, identifying a high-risk subgroup. The occurrence of clinically significant DVT despite routine pharmacological prophylaxis supports the need for risk-adapted diagnostic strategies, including targeted use of venous Doppler ultrasound.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Gonçalves Neves OM, Neves Lima G, Santos Nunes P, et al. Deep Vein Thrombosis in Hospitalized Patients with COVID-19: Incidence, Distribution, Predictors, and Clinical Outcomes in a Brazilian Tertiary Center. Ann Vasc Surg. 2026. PMID: 42520957. doi:10.1016/j.avsg.2026.07.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。